Disease · MONDO_0001673
Trials72
Trials an Open Targets clinical report links to the disease, posted results first, then the largest. A trial is shown when the release's checks confirm its link to the disease and Drugs and targets shows its link to one of the disease's drugs. 8 more are not shown, since the checks do not confirm them.
1 to 20 of 72
Download this page as JSON| Trial | Title | Phase | Participants | Results first posted | Conditions | Drugs | Linked by | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00547898 | Safety and Effectiveness of 3 Doses of Crofelemer Compared to Placebo in the Treatment of HIV Associated Diarrhea | Phase 3 | 374 | 2020-09-03 | HIV Associated Diarrhea | CROFELEMER | Its record names the disease | ClinicalTrials.gov |
| NCT01142089 | Study to Evaluate Safety and Efficacy of Rifamycin SV Multi-Matrix System (MMX) for the Treatment of Traveler's Diarrhea (TD) | Phase 3 | 264 | 2018-04-10 | Traveler's Diarrhea | RIFAMYCIN SODIUM | Open Targets' reading of its record | ClinicalTrials.gov |
| NCT01374490 | Safety and Tolerability of Crofelemer for HIV-Associated Diarrhea | Phase 3 | 250 | 2020-08-17 | HIV Enteropathy, Diarrhea With HIV | CROFELEMER | Its record names the disease | ClinicalTrials.gov |
| NCT01718873 | Optimization of Bevacizumab Scheduling With Chemotherapy for Metastatic Colorectal Cancer | Phase 3 | 230 | 2023-04-12 | Colorectal Cancer | BEVACIZUMAB, CAPECITABINE, FLUOROURACIL, OXALIPLATIN | Its record names the disease | ClinicalTrials.gov |
| NCT03633344 | Efficacy of the Administration of Colloidal Silicon Dioxide in Tablet Dosage Form in Patients With Acute Diarrhea | Phase 2 | 145 | 2019-06-06 | Diarrhoea;Acute | SILICON DIOXIDE | Its record names the disease | ClinicalTrials.gov |
| NCT00774930 | An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid Syndrome | Phase 3 | 115 | 2016-02-09 | Carcinoid Syndrome | LANREOTIDE | Its record names the disease | ClinicalTrials.gov |
| NCT04150250 | Cholera Anti-Secretory Treatment Trial | Phase 2 | 47 | 2021-03-25 | Cholera | IOWH-032 | Its record names the disease | ClinicalTrials.gov |
| NCT01591863 | Safety, Tolerability, and Pharmacokinetics of Fidaxomicin in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD) | Phase 2 | 38 | 2015-03-17 | Clostridium Difficile-associated Diarrhea | FIDAXOMICIN | Open Targets' reading, confirmed by NLM's indexing of its papers | ClinicalTrials.gov |
| NCT03473561 | Study to Evaluate the Efficacy and Safety of Racecadotril in Children Aged 3 to 60 Months Suffering From Acute Diarrhea | Phase 3 | 31 | 2023-11-24 | Diarrhea, Infantile | RACECADOTRIL | Its record names the disease | ClinicalTrials.gov |
| NCT02920242 | A Study Comparing Two Rifaximin Tablets in Patients With Travelers' Diarrhea. | Phase 3 | 28 | 2019-03-25 | Travelers' Diarrhea | RIFAXIMIN | Open Targets' reading of its record | ClinicalTrials.gov |
| NCT03767257 | A Study of Colesevelam for Lenalidomide-Associated Diarrhea | Phase 2 | 25 | 2025-10-21 | Multiple Myeloma, Diarrhea | COLESEVELAM | Its record names the disease | ClinicalTrials.gov |
| NCT00853047 | Study of Telotristat Etiprate (LX1606) in Participants With Symptomatic Carcinoid Syndrome Not Managed by Stable-Dose Octreotide Therapy | Phase 2 | 23 | 2018-12-26 | Carcinoid Syndrome | OCTREOTIDE, TELOTRISTAT | Its record names the disease | ClinicalTrials.gov |
| NCT00304356 | Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile Infection | Phase 3 | 22 | 2017-12-15 | Clostridium Enterocolitis, Pseudomembranous Colitis | NITAZOXANIDE | Its record names the disease | ClinicalTrials.gov |
| NCT04486326 | Crofelemer for Functional Diarrhea | Phase 4 | 17 | 2026-03-10 | Diarrhea | CROFELEMER | Its record names the disease | ClinicalTrials.gov |
| NCT04046328 | Efficacy, Safety and Tolerability of Enteric-Coated Cholestyramine Capsules for Adult Short Bowel Syndrome | Phase 2 | 13 | 2022-07-19 | Short Bowel Syndrome | CHOLESTYRAMINE | Its record names the disease | ClinicalTrials.gov |
| NCT02991768 | Budesonide for Mycophenolic Acid-induced Diarrhea in Renal Transplant Recipients | Phase 2 | 9 | 2024-09-19 | Diarrhea | BUDESONIDE | Its record names the disease | ClinicalTrials.gov |
| NCT01327300 | Efficacy of Mesalamine in Diarrhea-predominant Irritable Bowel Syndrome (dIBS) | Phase 2 | 7 | 2014-02-12 | Irritable Bowel Syndrome | MESALAMINE | Its record names the disease | ClinicalTrials.gov |
| NCT02619812 | Manage Diarrhea in Patients With Multiple Myeloma While Receiving Conditioning Chemotherapy for Autologous SCT | Phase 2 | 4 | 2017-06-14 | Multiple Myeloma | COLESEVELAM HYDROCHLORIDE | Its record names the disease | ClinicalTrials.gov |
| NCT04456517 | Reduce Crohn's-Associated Diarrhea With Sodium Channel Therapy | Phase 2 | 4 | 2025-02-06 | Crohn's Disease, Inflammatory Bowel Disease | RANOLAZINE | Its record names the disease | ClinicalTrials.gov |
| NCT01346059 | Intracolonic Vancomycin Therapy in Severe C. Diff Colitis | Not applicable | 2 | 2017-03-29 | Colitis | VANCOMYCIN | Its record names the disease | ClinicalTrials.gov |
diseases-2026-09-18-0.1.0
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/diseases/v1/MONDO_0001673/trials